INVO Fertility, Inc. shareholders approved increasing authorized shares from 6.25 million to 250 million on January 22, 2026, as well as other key measures including the appointment of a new accountant and adjustments to stock plans. This significant event signifies a strategic expansion in the company’s capital structure and investor engagement.